V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007700 | 290004767 | 1.9 | 54.4 | Palliative (P) | 2017-11-12 | 2017-11-13 | INTERAACT trial | N | N | 290018486 | GEMCITABINE |
| 290007701 | 290004768 | 1.7 | 62.5 | Palliative (P) | 2017-11-26 | 2017-12-07 | Capecitabine 35days + RT | 02 | Y | 290018491 | CARBOPLATIN + PACLITAXEL |
| 290007702 | 290004771 | 1.85 | 65.8 | Palliative (P) | 2017-09-26 | 2017-11-08 | Capecitabine + Mitomycin | 02 | N | 290018527 | NIVOLUMAB |
| 290007703 | 290004773 | 1.8 | null | null | 2015-10-25 | 2015-12-23 | Capecitabine 35days + RT | N | null | 290018530 | LANREOTIDE |
| 290007704 | 290007024 | 1.8 | null | Curative (C) | 2016-07-09 | 2016-07-10 | Cisplatin 7 day | N | N | 290018548 | CARBOPLATIN + RT |
| 290007705 | 290004775 | null | 67.2 | Disease modification (D) | 2018-02-10 | 2018-02-19 | CAV | N | N | 290018549 | ABVD |
| 290007706 | 290004776 | 1.7 | 79.3 | Palliative (P) | 2016-06-30 | 2016-06-30 | Docetaxel | 02 | N | 290018568 | PACLITAXEL |
| 290007707 | 290004779 | 1.87 | 71.7 | Disease modification (D) | 2018-09-29 | 2018-09-30 | Abiraterone | 02 | N | 290018587 | RITUXIMAB |
| 290007708 | 290004780 | 1.56 | 33 | Palliative (P) | 2014-01-25 | 2014-02-06 | Trabectedin | N | Y | 290018588 | CAPECITABINE + CISPLATIN |
| 290007709 | 290004783 | 1.6 | 79.04 | Palliative (P) | 2016-03-08 | 2016-03-10 | CISPLATIN + RT | 02 | null | 290018616 | IRINOTECAN |
| 290007710 | 290004785 | 1.55 | 72.4 | null | null | 2014-03-08 | Capecitabine + Mitomycin | 2 | N | 290018646 | LANREOTIDE |
| 290007711 | 290004787 | 1.62 | 75.5 | Palliative (P) | 2017-08-08 | 2017-09-04 | CAPECITABINE + RT | 01 | N | 290018648 | CETUXIMAB + IRINOTECAN + MDG |
| 290007712 | 290004792 | null | null | Palliative (P) | 2018-06-02 | 2018-07-25 | ECX | N | N | 290018681 | CAPECITABINE + OXALIPLATIN |
| 290007713 | 290004795 | 1.55 | 58.1 | Palliative (P) | 2016-04-20 | 2016-05-13 | Trastuzumab 21 day maintenance | 02 | null | 290018684 | LANREOTIDE |
| 290007714 | 290004796 | 1.84 | 53.2 | Curative (C) | 2016-01-23 | 2016-02-05 | Cetuximab + CISPLATIN + FLUOROURACIL | N | Y | 290018686 | CARBOPLATIN |
| 290007715 | 290007036 | 1.52 | null | Palliative (P) | 2016-11-01 | 2017-02-06 | Trastuzumab 21 day maintenance | null | null | 290018689 | CAPECITABINE + CARBOPLATIN |
| 290007716 | 290004799 | 1.71 | 82.3 | Palliative (P) | 2016-09-18 | 2016-10-13 | LANREOTIDE | 2 | null | 290018699 | CAPECITABINE + OXALIPLATIN |
| 290007717 | 290004800 | 1.74 | 81.2 | null | 2014-05-04 | 2014-06-25 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | 290018700 | CETUXIMAB |
| 290007718 | 290004802 | 1.88 | 98 | Palliative (P) | 2018-10-18 | 2018-10-20 | Capecitabine | 02 | N | 290018707 | CAPECITABINE + CISPLATIN |
| 290007719 | 290004803 | null | 54.6 | Palliative (P) | 2017-07-16 | 2017-07-19 | Docetaxel | N | N | 290018724 | CETUXIMAB |
| 290007720 | 290004804 | 1.57 | 57.9 | Curative (C) | 2017-12-12 | 2017-12-16 | Trial Unspecified | 02 | N | 290018743 | CAPECITABINE |
| 290007721 | 290004806 | 1.65 | 101.9 | Adjuvant (A) | 2018-05-11 | 2018-05-11 | LANREOTIDE | 02 | N | 290018744 | CAPECITABINE |
| 290007722 | 290004809 | 1.87 | 66.8 | Adjuvant (A) | 2018-03-17 | 2018-05-12 | Capecitabine | N | null | 290018751 | CAPECITABINE |
| 290007723 | 290004810 | 0 | 57 | Palliative (P) | 2017-08-22 | 2017-11-05 | Cetuximab 7 day (>Cycle 2) | N | N | 290018754 | INTERAACT TRIAL |
| 290007724 | 290004814 | 1.67 | 80.7 | Palliative (P) | 2015-12-13 | 2015-12-19 | PACLITAXEL | N | null | 290018789 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290007725 | 290004817 | 1.76 | 83 | Palliative (P) | 2014-02-06 | 2014-02-15 | Rituximab | N | N | 290018796 | SUNITINIB |
| 290007726 | 290004819 | 1.77 | 51.6 | Not known (9) | 2017-01-29 | 2017-06-11 | CISPLATIN + RT | N | null | 290018811 | LANREOTIDE |
| 290007727 | 290004821 | 1.8 | 54.9 | null | 2016-09-23 | 2016-09-23 | Bevacizumab 15mg/kg | 2 | N | 290018815 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 290007728 | 290004824 | 0 | 61.6 | Palliative (P) | 2015-10-18 | 2015-10-18 | MITOMYCIN | 02 | N | 290018852 | DOCETAXEL |
| 290007729 | 290004826 | 1.6 | 93.1 | Palliative (P) | 2017-02-18 | 2017-02-20 | MITOMYCIN | N | N | 290018862 | EVEROLIMUS |
| 290007730 | 290004826 | null | 88.4 | Palliative (P) | 2018-02-06 | 2018-02-24 | Cetuximab + Radiotherapy Maint | 02 | null | 290018862 | DOCETAXEL |
| 290007731 | 290004829 | null | 98 | Palliative (P) | 2014-02-10 | 2014-02-10 | Capecitabine + Oxaliplatin 21day | N | null | 290018888 | LANREOTIDE |
| 290007732 | 290004830 | 1.78 | 38.8 | Adjuvant (A) | 2016-03-16 | 2016-04-16 | Capecitabine | 2 | N | 290018906 | CAPECITABINE + MITOMYCIN |
| 290007733 | 290004831 | null | 70.7 | Palliative (P) | 2015-05-23 | 2015-05-23 | REGORAFENIB | 02 | N | 290018938 | NOT MATCHED |
| 290007734 | 290004834 | 1.65 | null | Palliative (P) | 2017-10-17 | 2017-11-23 | CAPECITABINE + OXALIPLATIN | N | N | 290018953 | IRINOTECAN |
| 290007735 | 290007052 | null | null | Curative (C) | 2016-05-19 | 2016-06-16 | Capecitabine | 2 | N | 290018982 | CETUXIMAB |
| 290007736 | 290004838 | 0 | 76.1 | Palliative (P) | 2016-12-22 | 2016-12-30 | Capecitabine + Mitomycin | 2 | N | 290018997 | SUNITINIB |
| 290007737 | 290004840 | 1.8 | 95 | Curative (C) | 2014-02-27 | 2014-03-26 | Carboplatin + Etoposide iv&po | 02 | N | 290019008 | CARBOPLATIN + RT |
| 290007738 | 290004842 | 1.8 | 108 | Palliative (P) | 2018-04-23 | 2018-04-24 | Cisplatin + Radiotherapy | N | N | 290019011 | CAPECITABINE + CISPLATIN |
| 290007739 | 290004846 | 1.6 | null | null | 2016-01-12 | 2016-07-04 | FLUOROURACIL + MITOMYCIN | 02 | N | 290019042 | LANREOTIDE |
| 290007740 | 290004850 | 1.57 | null | Palliative (P) | 2016-03-25 | 2016-04-07 | CISPLATIN + GEMCITABINE | 2 | N | 290019080 | ECX |
| 290007741 | 290004853 | null | 77.6 | null | 2014-10-27 | 2014-12-01 | Ralitrexed | 2 | N | 290019084 | LANREOTIDE |
| 290007742 | 290007943 | 1.65 | 108.7 | Palliative (P) | 2015-12-04 | 2015-12-04 | PACLITAXEL | 02 | N | 290019094 | CETUXIMAB |
| 290007743 | 290004860 | 1.79 | 69.45 | Palliative (P) | 2015-05-31 | 2015-05-31 | Cisplatin + Radiotherapy | 02 | N | 290019112 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290007744 | 290004867 | 1.8 | 52.7 | Palliative (P) | 2016-09-11 | 2016-10-09 | Rituximab | 02 | Y | 290019175 | CETUXIMAB + CISPLATIN + FU |
| 290007745 | 290004870 | 1.56 | 44.1 | Disease modification (D) | 2014-08-08 | 2014-08-13 | CARBOPLATIN + RT | 2 | N | 290019178 | CAPECITABINE + MITOMYCIN + RT |
| 290007746 | 290004871 | 0 | 49.4 | Palliative (P) | 2017-08-05 | 2017-08-26 | Cisplatin + Radiotherapy | 2 | N | 290019189 | CETUXIMAB + MDG |
| 290007747 | 290004876 | 1.64 | 64.2 | null | 2016-10-31 | 2016-10-31 | Cisplatin + Radiotherapy | N | N | 290019233 | CAPECITABINE |
| 290007748 | 290004880 | 1.55 | 45 | Adjuvant (A) | 2016-06-20 | 2017-01-22 | Capecitabine + Oxaliplatin 21day | null | null | 290019237 | CAPECITABINE |
| 290007749 | 290004883 | 1.53 | 76 | Palliative (P) | 2015-11-28 | 2016-02-19 | CETUXIMAB | N | null | 290019258 | CARBOPLATIN + ETOPOSIDE |